logo

For the Inventor, By the Inventor

Fremont, CA, United States of America

Camellia Zamiri

This inventor holds 13 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents. Top assignees: Ekr Therapeutics, Inc., Abbvie Inc., Chiesi USA, Inc.. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camellia Zamiri. Retrieved from https://idiyas.com/inventor/camellia-zamiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 100.0


Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 55(Granted Patents)


Company Filing History:

goldMedal9 out of 9 
 
Ekr Therapeutics, Inc.
 patents
silverMedal3 out of 827 
 
Abbvie Inc.
 patents
bronzeMedal1 out of 1 
 
Chiesi USA, Inc.
 patent

Years Active: 2009-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12383622 - Pre-mixed, ready-to-use pharmaceutical compositions (2025-08-12),
2. 11547758 - Pre-mixed, ready-to-use pharmaceutical compositions (2023-01-10),
3. 10758616 - Pre-mixed, ready-to-use pharmaceutical compositions (2020-09-01),
4. 9944720 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2018-04-17),
5. 9549994 - Compositions of nicardipine and sulfoalkylated β-cyclodextrin (2017-01-24),
6. 9370586 - Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions (2016-06-21),
7. 9364564 - Pre-mixed, ready-to-use pharmaceutical compositions (2016-06-14),
8. 9163093 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2015-10-20),
9. 9045551 - Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof (2015-06-02),
10. 8455524 - Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions (2013-06-04),
11. 7659291 - Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions (2010-02-09),
12. 7659290 - Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions (2010-02-09),
13. 7612102 - Pre-mixed, ready-to-use pharmaceutical compositions (2009-11-03),

Title: The Innovative Contributions of Camellia Zamiri

Introduction

Camellia Zamiri is a prominent inventor based in Fremont, CA, known for her significant contributions to the field of pharmaceuticals. With a total of 13 patents to her name, she has made remarkable strides in developing ready-to-use pharmaceutical compositions that address critical health issues.

Latest Patents

Among her latest patents are innovative pre-mixed, ready-to-use pharmaceutical compositions of nicardipine or its pharmaceutically acceptable salts. These compositions are designed for use in treating cardiovascular and cerebrovascular conditions, showcasing her commitment to improving patient care through effective medication solutions.

Career Highlights

Throughout her career, Camellia has worked with notable companies such as Ekr Therapeutics, Inc. and AbbVie Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking advancements in pharmaceutical technology.

Collaborations

Camellia has collaborated with talented individuals in her field, including Supriya Gupta and Michelle Renee Duncan. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of her work.

Conclusion

Camellia Zamiri's contributions to the pharmaceutical industry exemplify her dedication to innovation and improving healthcare outcomes. Her patents and collaborations reflect her significant role in advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…